| Serial Number | 79309367 |
| Word Mark | TARGINTA |
| Filing Date | Thursday, February 4, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 12, 2022 |
| Registration Number | 6784066 |
| Registration Date | Tuesday, July 12, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 26, 2022 |
| Goods and Services | Pharmaceutical and veterinary preparations for the treatment of cancer and for cancer therapies used in the treatment of cancer; stem cells for medical purposes; stem cells for medical and veterinary use; DNA and RNA for medical and veterinary purposes, namely, gene-based RNA molecular network biomarker reagents for medical diagnosis purposes, Medical therapeutic preparations in the nature of biologically active antisense DNA or RNA compounds, Biological products for medical use in recombinant DNA technology in the nature of DNA products allowing recombinant production of polypeptides and monoclonal antibodies; surgical implants grown from stem cells comprising living tissues; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; biological preparations for the treatment of cancer for medical and veterinary purposes; diagnostic kit consisting of stem cells, monoclonal antibodies and proteins for use in disease testing for medical and veterinary purposes; Reagents for medical use, namely, reagents for medical diagnosis and analysis; diagnostic preparations for medical and veterinary use |
| Goods and Services | Biological preparations for use in industry and science; stem cells for research or scientific purposes; antibodies for research and industrial purposes, namely, Biochemicals in the nature of monoclonal antibodies for in vitro scientific or research use, Laboratory chemicals in the nature of an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use, Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; DNA and RNA for scientific and industrial purposes, namely, Test particles for biodetection systems, biological analogues and microscopic carrier beads with chemically attached DNA fragments for use in testing the operation of equipment used for analyzing air for the presence of harmful biological substances, Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields, Reagent kit comprising enzyme and chemicals for in vitro transcription of RNA and modified RNA, Gene-based RNA molecular network biomarker reagents for research purposes; proteins for use in science being protein in raw material form for scientific research; chemical test kits, consisting of stem cells, antibodies and proteins, for scientific and industrial purposes for laboratory or research use; reagents for scientific purposes; diagnostic reagents for scientific purposes, not for medical or veterinary purposes; analytical preparations being Chemical buffer and standard solutions used in analytical chemistry, Reagents used for analytical moisture determinations, Reagents for use in scientific apparatus for chemical or biological analysis, Laboratory chemicals in the nature of an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use, Chemical substances for analyses in laboratories, other than for medical or veterinary purposes for scientific purposes related to cancer treatment and therapies |
| Translation of Words in Mark | The wording "TARGINTA" has no meaning in a foreign language. |
| Goods and Services | Scientific research; laboratory testing services, namely, scientific research, diagnosis, testing and analysis in the fields of medicine, chemistry, stem cells, RNA, DNA, antibodies and proteins; basic and clinical research in the field of respiratory science and medicine, in particular in relation to the development of medicines; research and development services in the field of diagnostic preparations; quality control for others |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 23, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 23, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 23, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Targinta AB |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | SE |
| Party Name | Targinta AB |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | SE |
| Party Name | Targinta AB |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | SE |
| Event Date | Event Description |
| Wednesday, October 19, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, October 19, 2022 | FINAL DISPOSITION PROCESSED |
| Wednesday, October 12, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, July 12, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, July 12, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 3, 2022 | NOTIFICATION PROCESSED BY IB |
| Tuesday, April 26, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 26, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 13, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, April 13, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, April 6, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, March 24, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, March 24, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, March 24, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 24, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 24, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, March 16, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 15, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 15, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 9, 2022 | ASSIGNED TO EXAMINER |
| Monday, October 25, 2021 | REFUSAL PROCESSED BY IB |
| Monday, September 27, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, September 27, 2021 | REFUSAL PROCESSED BY MPU |
| Friday, September 10, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, September 9, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, August 27, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, April 27, 2021 | APPLICATION FILING RECEIPT MAILED |
| Friday, April 23, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, April 22, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |